Rocket


Overview
Financials
News + Filings

 
 

Zander Therapeutics, Inc Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsJun-30-19Jun-30-18Jun-30-17Jun-30-16
Revenues0.00.0  
Cost of goods sold1.80.0  
Gross profit-1.80.0  
            Gross margin-15095.8%   
Selling, general and administrative1.60.2  
Research and development0.61.7  
General and administrative0.90.1  
EBIT-1.4-1.9  
            EBIT margin-12090.5%   
Pre-tax income0.3-2.2  
Income taxes0.00.0  
            Tax rate0.0%0.0%  
Net income0.0-2.2  
            Net margin365.9%   
 
Diluted EPS$0.01($0.51)  
Shares outstanding (diluted)6.04.3  
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy